Case-Based Roundtable Meetings Spotlight: March 2022

Roundtable Discussion: Kuzel Walks Through New Treatment Options in Advanced RCC

March 30, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Timothy Kuzel, MD, discussed risk assessment and later-line treatment options for a patient diagnosed with metastatic renal cell carcinoma who received lenvatinib and pembrolizumab.

Gopal Addresses Differences Between Real-World and Clinical Trial Data for DLBCL

March 22, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Ajay K. Gopal, MD, discussed the options for second-line and subsequent treatment of a patient with relapsed/refractory diffuse large B-cell lymphoma who refuses CAR T-cell therapy.

Roundtable Discussion: Isaacs Discusses Second- and Third-Line Therapy for Patients with TNBC

March 21, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Claudine Isaacs, MD, discussed treatment options for a patient with triple-negative breast cancer whose condition worsened after first-line gemcitabine plus carboplatin.

Roundtable Discussion: Salit Explores Use of Steroids and Therapy for Acute GVHD

March 19, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Rachel B. Salit, MD, discussed the case of a patient with acute graft versus host disease, steroid dependence, and therapy for steroid-refractory disease.